Johnson & Johnson (JNJ) SEC News Jan. 21, 2026, 12:46 UTC (10% Negative) Johnson & Johnson (JNJ) Reports Q1 2026 Financial Results Full text
Register to leave comments News bot Jan. 29, 2026, 7:40 p.m. 📋 Johnson & Johnson (JNJ) - Financial Results Filing Date: 2026-01-21 Accepted: 2026-01-21 07:46:18 Event Type: Financial Results Event Details: Johnson & Johnson (JNJ) Reports the reporting period Financial Results Johnson & Johnson (JNJ) announced its financial results for the period ending the reporting period. Key Financial Highlights: Revenue: $24,564 Net Income: $6,009 EPS: $2.46 Cash and equivalents: $19,700 📊 Key Financial Metrics: Metric Value Eps $2.46 Revenue $24,564 Net Income $6,009 Cash $19,700 💼 Business Developments: PartnershipAcquisitionLicensing: Not availableRegulatory ApprovalExecutive Changes: Not available Structured Data: Company Name: Johnson & JohnsonTicker Symbol: JNJ
📋 Johnson & Johnson (JNJ) - Financial Results
Filing Date: 2026-01-21
Accepted: 2026-01-21 07:46:18
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics:
💼 Business Developments:
Structured Data: